. Author manuscript; available in PMC: 2014 Oct 15.

Published in final edited form as: J Neuroimmunol. 2013 Jul 29;263(0):10.1016/j.jneuroim.2013.07.014. doi: 10.1016/j.jneuroim.2013.07.014

Table 1.

Th1 and Th17 responses of donor animals based on treatment status.

	Number of animals with Th1(+) and Th17(+) responses
	Naïve/sham	MCAO; LPS(−)	P
Th1(+)	0/9	2/8 (25%)	0.11
Th17(+)	0/9	5/8 (62%)	<0.01
	Naïve/sham	MCAO; LPS(+)	P

Th1(+)	0/9	10/18 (56%)	<0.01
Th17(+)	0/9	9/18 (50%)	<0.01
	MCAO; LPS(−)	MCAO; LPS(+)	P

Th1(+)	2/8 (25%)	10/18 (56%)	0.15
Th17(+)	5/8 (62%)	9/18 (50%)	>0.20

Th1(+) indicates a Th1 response > 1.16, Th17(+) response indicates a Th17(+) response >1.15 as defined in the methods section. MCAO = middle cerebral artery occlusion, LPS = lipopolysaccharide, LPS(+) = treated with LPS at the time of MCAO, LPS(−) = treated with saline at the time of MCAO. Statistics are by χ².

Bold indicates significant results (P < 0.05).